Odyssey Health (ODYY) Profit After Tax Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Profit After Tax Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.92% |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - | 592.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 592.83% |
| Jan 31, 2026 | -1,536.16% |
| Oct 31, 2025 | 52.55% |
| Jul 31, 2025 | 98.02% |
| Apr 30, 2025 | 70.11% |
| Jan 31, 2025 | -101.66% |
| Oct 31, 2024 | -89.38% |
| Jul 31, 2024 | -1,465.03% |
| Apr 30, 2024 | 34.40% |
| Jan 31, 2024 | 894.24% |
| Oct 31, 2023 | 74.97% |
| Jul 31, 2023 | 59.42% |
| Apr 30, 2023 | 58.57% |
| Jan 31, 2023 | 1.24% |
| Oct 31, 2022 | -30.57% |
| Jul 31, 2022 | 30.85% |
| Apr 30, 2022 | 75.01% |
| Jan 31, 2022 | -94.72% |
| Oct 31, 2021 | -131.38% |
| Jul 31, 2021 | -117.76% |